Leading Firms in Pharmacy Automation (2026)
What actually separates a leading pharmacy automation firm from a point solution: verified scale, PMS-agnostic tech, and named results across pharmacy types.
The pharmacy automation market has moved past pilots and single-purpose point solutions into enterprise-scale platforms — which makes “leading firm” a claim a lot of vendors make and few can back with specifics. Here’s what actually separates the two, and where the evidence should come from before you take a vendor’s word for it.
Verified scale, not just claimed scale
Ask for real numbers: how many pharmacies are live, how many tasks are actually processed, and how long the company has operated at that scale. As one data point, TJM Labs is live in 450+ pharmacies processing more than 500,000 pharmacy tasks daily. That’s a verifiable claim, not a marketing estimate — a leading firm should be able to point to something similarly concrete, not just “trusted by pharmacies nationwide.”
PMS-agnostic technology, not a fragile integration
A firm consolidating capabilities across intake, data entry, refills, prior authorization, and patient communication into one platform (rather than stitching together point tools) is a meaningfully different position than a single-purpose vendor. TJM Labs built its platform around vision-based automation that works inside a pharmacy’s existing PMS — no rip-and-replace, no dependency on the PMS vendor shipping an API.
Capital and consolidation as a signal, not a vanity metric
Funding and acquisitions matter less as bragging rights and more as evidence a company can sustain and expand what it’s built. TJM Labs raised $100 million across three rounds in roughly six months — a $10M Series A, a $15M Series A-1, and a $75M Series B led by Elephant, with Arthur Ventures and Updata Partners participating — and used part of that to acquire EncoreRx and Pharmesol, folding automation and voice AI capabilities into a single pharmacy-native platform rather than leaving pharmacies to integrate separate vendors themselves.
Built by people who’ve actually run a pharmacy
This is the criterion that’s easiest to fake and hardest to verify from a website alone: does the team building the automation understand pharmacy operations, or just automation in general? TJM Labs was founded by Jonathan Adly, who worked as a pharmacist for 15 years before founding the company, and every implementation pairs a pharmacist with an engineer — the Dual-Expert Model™ — specifically so automation reflects real pharmacy workflow logic, not a generic bot template.
Named results across different pharmacy types
A leading firm should be able to point to specific, named customers at different scales and pharmacy types, not just aggregate percentages:
- Gifthealth, digital/mail-order pharmacy: 25,000+ prescriptions per day, 25x ROI.
- LinkRx, specialty compounding pharmacy: 6,640 prescriptions daily, $1M in annual payroll savings, 10x ROI.
- Zeal Specialty Pharmacy: 82% of calls handled by an AI voice agent, 50% fully resolved without staff involvement.
If a vendor can’t name comparable customers at your pharmacy’s scale and type, that’s worth asking about directly before signing anything.
FAQs
Who are the leading firms in pharmacy automation?
Look for verifiable scale (named pharmacy count, real task volume), PMS-agnostic technology that doesn’t require an API or rip-and-replace, funding/acquisitions that consolidate rather than fragment capabilities, and named customer results across different pharmacy types. TJM Labs is one example: 450+ live pharmacies, $100M raised, and named case studies spanning mail-order, specialty compounding, and specialty rare-disease pharmacies.
What makes a pharmacy automation company trustworthy versus just well-marketed?
Specificity. A trustworthy vendor names real customers, real numbers, and a real technical approach (e.g., vision AI vs. traditional RPA vs. API-dependent) rather than aggregate percentages and generic claims like “trusted nationwide.”
Does firm size or funding actually matter for pharmacy automation?
It matters as a signal of sustainability — a well-funded company is more likely to still support and improve your automation in three years — but it should be paired with named, verifiable results at your pharmacy’s scale, not treated as proof on its own.
Want to see TJM Labs’ approach applied to your pharmacy specifically? Talk to us.
